The Wohl & Fruchter LLP Law Firm is Investigating the Acquisition of Auxilium Pharmaceuticals, Inc. by QLT, Inc.
NEW YORK--(BUSINESS WIRE)--The law firm of Wohl & Fruchter LLP is investigating the proposed acquisition of Auxilium Pharmaceuticals, Inc. (Auxilium) (Nasdaq:AUXL) by QLT, Inc. (QLT).
On June 26, 2014, Auxilium announced that it had entered into agreement under which Auxilium will merge with QLT. Under the agreement, Auxilium shareholders will receive 3.1359 QLT shares for each Auxilium share, subject to certain adjustments.
Wohl & Fruchter’s investigation concerns the adequacy of the consideration being paid to AUXL shareholders, and whether the board of directors of Auxilium breached their fiduciary duties to AUXL shareholders.
Persons with relevant information, and AUXL shareholders with questions about this investigation, are invited to contact our Firm by calling 866.833.6245, or contacting the attorney below.
Additional information is available at http://www.wohlfruchter.com/cases/auxl.
About Wohl & Fruchter
Wohl & Fruchter LLP represents plaintiffs in litigation arising from fraud and other fiduciary breaches by corporate managers, as well as other complex litigation matters. Please visit our website, www.wohlfruchter.com, to learn more about our Firm, or contact one of our partners.
This release may be deemed to constitute attorney advertising.